Intravenous Immunoglobulin (Ivig) Market Size & Share Forecast Till 2025 Availab

Posted by Nita on November 16th, 2019

Global Intravenous Immunoglobulin (IVIg) Market Research Report - Forecast To 2023

The global market for Intravenous Immunoglobulin (IVIg) market is growing continuously and expected to grow at a CAGR of 5.9% from 2016 to 2023

Taste the market data and market information presented through more than 64 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Intravenous Immunoglobulin (IVIg) Market Research Report –Global Forecast to 2023.”

Market Highlights

The global Intravenous Immunoglobulin (IVIg) market has been evaluated as moderately growing market and it is expected that the market will continue to grow similarly in the near future. The demand for new products and therapy is growing continuously. The market for Intravenous Immunoglobulin (IVIg) was around US$ 5910.8 million in 2016 and is expected to grow at a CAGR of 5.9% by 2023.

There are plenty of large and small market players which operate in this market: ABEONA THERAPEUTICS (US), Baxter (US), BDI Pharma (US), Biotest AG.(Germany),, China Biologic Products, Inc. (China), CSL Behring (US), Grifols Inc. (Spain), Kedrion S.p.A (us), Octapharma (Switzerland), Shire (Republic of Ireland), AND others.

Biotest AG. Was found in 1946 and based in Germany. Biotest AG is one of the key players in the market. This company employed about 2,527 people throughout the world and total revenue of the company is US$ 622.7million in 2016. In May 2017, Biotest AG sold their US therapy business to ADMA Biologics, Inc. and received specified current products and a rights related to first order for distribution of upcoming products of ADMA Biologics, Inc. in Europe and selected parts of Asia and middle East.

Global Intravenous Immunoglobulin (IVIg) Market information, by type (IgA, IgD, IgE, IgG, IgM), by Appliaction (Chronic inflammatory demyelinating polyneuropathy (CIDP), Hypogammaglobulinemia, Multifocal Motor Neuropathy, Immunodeficiency diseases, Primary Humoral Immunodeficiency, Myasthenia Gravis, Guillain-Barre syndrome, Kawasaki disease, ITP, and others) - Forecast to 2023 : https://www.marketresearchfuture.com/reports/intravenous-immunoglobulin-market-3137

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.